Floatz logo

FLUOROURACILUM

Human Papilloma Virus Infection

AIDS Malignancy ConsortiumSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Human Papilloma Virus Infection cohort.

Asset / SponsorPhaseRating
Gardasil 9 Vaccine
Eunice Dube
Phase 4BBB
HUMAN PAPILLOMAVIRUS SEROTYPE 58 WHOLE
Beijing Health Guard Biotechnology, Inc
Phase 3BB
Recombinant Nonavalent Human Papillomavirus Vaccine
Beijing Health Guard Biotechnology, Inc
Phase 3BB
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB
Imiquimod
AIDS Malignancy Consortium
Phase 3B

View all 16 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →